Automobile production meanwhile rose 29 percent to 1.14 million units.
She cited a cut in sales taxes on automobile purchases.
Do you think that maybe this could work here, no they think that raising taxes will work better. You know that maybe if prices were lower so people could buy CARS, or any thing that they would like, then maybe BUSINESS just mite come back to this COUNTRY, but every thing has so much tax, no one can run a business, or buy any thing. MAYBE Americans are not as smart as DC, or is that Americans are SMARTER then DC and we know why American products don’t sell. ( over PRICED, and over TAXED because of HIGH TAXES.
Lower TAXES mean more BUSINESS, more BUSINESS, means more INCOME, and more INCOME means less TAXES, not more, so wake up GOVERNMENT dummies.
by Dan Martin
BEIJING (AFP) – China’s May industrial output and retail sales both grew at a faster pace than in previous months, the government said Friday, as massive stimulus measures introduced since last year kicked in. Continue reading →
By LARRY MARGASAK and SHARON THEIMER, Associated Press Writers
WASHINGTON – Influential senators working to overhaul the nation’s health care system have investments and family ties with some of the biggest names in the industry. The wife of Sen. Chris Dodd, the lawmaker in charge of writing the Senate’s bill, sits on the boards of four health care companies.
Members of both parties have industry connections, including Democrats Jay Rockefeller and Tom Harkin, in addition to Dodd, and Republicans Tom Coburn, Judd Gregg, John Kyl and Orrin Hatch, financial reports showed Friday. .
Jackie Clegg Dodd, wife of the Connecticut Democrat, is on the boards of Javelin Pharmaceuticals Inc., Cardiome Pharma Corp., Brookdale Senior Living and Pear Tree Pharmaceuticals.
Dodd is filling in for ailing Sen. Edward Kennedy, D-Mass., chairman of the Health, Education, Labor and Pensions Committee, which will soon start work on a health care bill.
Other publicly available documents show Mrs. Dodd last year was one of the most highly compensated non-employee members of the Javelin Pharmaceuticals Inc. board, on which she has served since 2004. She earned $32,000 in fees and $109,587 in stock option awards last year, according to the company’s SEC filings. Continue reading →